ThinkCyte, Inc.
Edit

ThinkCyte, Inc.

https://thinkcyte.com/
Last activity: 06.05.2024
Categories: AnalyticsBioTechDevelopmentDiagnosticsDrugLearnOpticsResearchScienceTechnology
THINKCYTE integrate optics, genomics and information science to create “machines” that uncover and understand high-resolution information from single cells, with the goal of moving healthcare beyond the current horizon.
Mentions
10
Total raised: $26M

Investors 6

Funding Rounds 1

DateSeriesAmountInvestors
19.05.2021Series B$26M-

Mentions in press and media 10

DateTitleDescription
06.05.2024ThinkCyte Launches New Website and Showcases VisionSortTM at Global EventsTOKYO, May 7, 2024 /PRNewswire/ -- ThinkCyte today announced that it will be presenting at three major international scientific conferences in the first week of May and the launch of its updated website. The company will have a presence at ...
01.04.2024ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestonesTOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of a paper in the March issue of Cell Reports Methods on a new method for high-throughput drug discovery. Together with a joint research group including investig...
09.01.2024ThinkCyte Launches Partnering PlatformThinkCyte today announced the launch of its new partnering program for the biopharmaceutical and diagnostics industry. TOKYO, JAPAN, January 9, 2024 /EINPresswire.com/ -- ThinkCyte today announced the launch of its new partnering program fo...
12.10.2023NEDO「ディープテック・スタートアップ支援基金/ディープテック・スタートアップ支援事業」に採択シンクサイト株式会社は、国立研究開発法人新エネルギー・産業技術総合開発機構(NEDO)の「ディープテック・スタートアップ支援基金/ディープテック・スタートアップ支援事業」(以下、「DTSU」)のDMPフェーズ(量産化実証)に採択されました。 NEDOのDTSUは、技術の確立や事業化、社会実装までに長期の研究開発と大規模な資金を要するものの、国もしくはグローバルレベルで対処すべき社会課題を解決し得る、革新的な技術の研究開発に取り組む「ディープテック・スタートアップ」に対し、実...
19.05.2021ThinkCyte Secures $26M in Series B FundingThinkCyte, a Tokyo, Japan-based company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, raised $26m in Series B funding. The round was led by SPARX Group, Sysmex Corporation, Sumitomo Mitsui Trust...
19.05.2021ThinkCyte Secures $26 million in Series B FinancingTOKYO, May 19, 2021 /PRNewswire/ -- ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today the completion of a $26 million (JPY 2.85 billion) Series B financing...
19.05.2021ThinkCyte Secures $26 million in Series B Financing
12.05.2021Sysmex and ThinkCyte Agree on Joint Development and Capital AllianceTOKYO, May 12, 2021 /PRNewswire/ -- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and ThinkCyte, Inc. (HQ: Bunkyo-ku, Tokyo, Japan; CEO: Waichiro Katsuda) announced today the signing of joint development and invest...
18.06.2020Berkeley SkyDeck startups raise $32 million in funding in the midst of coronavirus pandemic shutdownThe last we covered UC Berkeley SkyDeck was back in March when the startup accelerator announced it biggest cohort from 11 countries, startups will collaborate remotely. Today, UC Berkeley SkyDeck announces that in the past six months, incl...
07.11.201820 startups take center stage at Berkeley SkyDeck’s demo dayThe largest-ever Berkeley SkyDeck demo day kicked off with a high-energy performance from the Cal marching band, setting the tone for an afternoon of presentations from none other than Berkeley faculty and students-turned-entrepreneurs. Lau...

Reviews 0

Sign up to leave a review

Sign up Log In